Overview

Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term pulmonary and cardiovascular safety of Exubera in routine clinical practice.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Treatments:
Insulin
Insulin, Globin Zinc